Cedars-Sinai Guerin Children’s pediatric specialists will share their expertise and recent research findings at the American Academy of Pediatrics Annual Meeting, taking place Oct. 7-11 in Anaheim, California.
UC San Diego researchers report significant decrease in national cases of Kawasaki disease during COVID-19 pandemic; findings hint at origins of disease.
COVID-19, MIS-C and KD all share a similar underlying mechanism involving the over-activation of particular inflammatory pathways, UC San Diego study shows. Findings support novel drug targets for MIS-C.
Researchers at University of California San Diego School of Medicine tested the same treatment for kids with Kawasaki disease and rare COVID-19 reaction.
A Rutgers pediatrician specializing in critical care discusses how to differentiate among multisystem inflammatory syndrome, acute COVID-19 and Kawasaki disease in children
New research shows that children with Kawasaki Disease remain at an increased risk for cardiovascular events more than 10 years after hospitalization for their condition, highlighting the need for long-term heart disease surveillance and risk reduction strategies for these young patients. Details of the study was presented at ACR Convergence, the American College of Rheumatology’s annual meeting.
Researchers at UC San Diego report that while Kawasaki disease occurs in clusters, the traits, and thus the triggers of the inflammatory disease vary among clusters.
MIS-C stands for multisystem inflammatory syndrome in children. Formerly called pediatric inflammatory multisystem syndrome, or PIMS, it describes a new health condition seen in children who have been infected with novel coronavirus, recovered from it and later have an immune response that results in symptoms of significant levels of inflammation in organ systems. MIS-C is similar in some ways to other inflammatory conditions like Kawasaki disease and toxic shock syndrome. Children who have MIS-C generally did not have obvious symptoms when they were infected with novel coronavirus, like cough, and generally were healthy prior to developing MIS-C.
Rutgers pediatricians co-lead first nationwide study describing the diagnosis, treatments and outcomes of COVID-19 related multiple inflammatory syndrome in children
Kawasaki disease, sometimes called Kawasaki syndrome, is a serious inflammation of the blood vessels which affects young children, often under 5 years of age. Marked by fever, swelling and other symptoms, it can lead to coronary artery aneurysms in approximately 25% of cases if untreated.
Experts Discuss Pediatric Inflammatory Multi-System Syndrome and its Potential Connection to COVID-19 in Pediatric Patients with Kawasaki Disease. Physicians urge community pediatricians and emergency room physicians to be on the lookout for children with prolonged fevers displaying several other symptoms – including rash, red cracked lips, or red tongue and red eyes, among others.
An international expert on pediatric infectious diseases, is concerned that people will attribute to Kawasaki disease the mysterious syndrome that was first reported in Europe and seen most recently in New York City children with COVID-19. However, the more likely explanation of this new entity is toxic shock syndrome, says Moshe Arditi, MD.
Recent reports from emergency rooms of children with symptoms of a rare inflammatory syndrome called Kawasaki disease have health experts concerned about the ailment’s possible link to COVID-19 and its threat to children. David Cennimo, a pediatrics and infectious disease…